The purpose of this study is to compare the efficacy of once daily dosing with Rhinocort Aqua (new formulation) against Rhinocort Aqua (current formulation) and placebo in reliving the symptoms of seasonal allergic rhinitis (SAR).
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Enrollment
200
Assessment of Total Nasal Symptom scores (Rhinorrhea, Congestion, Itching & Sneezing)
Time frame: 2 weekly
Durability of device
Time frame: End of study
Safety assessment via adverse events and clinical measurements
Time frame: 2 weekly
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.